報價延遲最少15分鐘:2026/04/03 23:32 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.32 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.06/0.02
|
|
企業價值
200.76M
|
| 資產負債 |
|
每股賬面淨值
0.37
|
| 現金流量 |
|
現金流量率
0.00
|
| 損益表 |
|
收益
41.13M
|
|
每股收益
0.64
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States. |
